Dawn Maroney files Form 144 to sell ALHC shares

Alignment Healthcare insider Dawn Maroney reported proposed sales of Common Stock via Form 144.

Rhea-AI Filing Summary

Alignment Healthcare insider Dawn Maroney reported proposed sales of Common Stock via Form 144. The filing lists shares acquired on 03/13/2024 through RSU vesting (32,500 shares) and on 03/13/2025 through RSU vesting (39,785 shares).

The filing also documents recent 10b5-1 sales attributed to Dawn Maroney, including 30000 shares on 03/16/2026, 29,113 shares on 03/12/2026 (proceeds $507,925.32), and multiple earlier 2026 executions such as 30000 shares on 02/17/2026 and 30000 shares on 01/15/2026. The schedule shows additional disposals in January and December 2025.

Insights

Insider Trading Analyst

TL;DR: Multiple Rule 10b5-1 sales by Dawn Maroney are disclosed, with RSU vesting dates noted.

The filing lists RSUs that vested on 03/13/2024 (32,500 shares) and 03/13/2025 (39,785 shares), establishing the source of shares offered. It separately records numerous 10b5-1 executions in late 2025 and early 2026, with individual sale sizes up to 282,070 shares on 12/29/2025 as shown.

These sales are presented as plan-driven transactions; their market impact depends on trading cadence and remaining plan parameters. Subsequent filings may provide further details on any remaining plan authorizations or post-transaction holdings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Dawn Maroney file in the Form 144 for ALHC?

She reported proposed sales of Common Stock under Form 144 and listed RSU vesting dates. The filing notes RSUs vested on 03/13/2024 (32,500 shares) and 03/13/2025 (39,785 shares), and multiple 10b5-1 sales.

How many shares were sold recently under the 10b5-1 plan?

The filing lists multiple recent dispositions with specific share counts and proceeds. Examples include 30,000 shares on 03/16/2026 and 29,113 shares on 03/12/2026 (proceeds $507,925.32).

Were the shares sold acquired from equity awards or open-market purchases?

The shares were acquired through RSU vesting events, not open-market purchases. The filing states acquisitions via vesting on 03/13/2024 and 03/13/2025 under the 2021 Equity Incentive Plan.

Do the Form 144 entries show proceeds from recent sales?

Yes, several sale rows list proceeds for specific executions. For example, the 03/12/2026 sale shows proceeds of $507,925.32, and other rows include dollar amounts alongside share counts.

Is the trading shown part of a pre-arranged plan?

Yes, the filing references a Rule 10b5-1 sales plan for Dawn Maroney for multiple executions. The 10b5-1 designation appears next to several dated sales entries in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/16/2026 - 09:35 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001850397
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Alignment Healthcare, Inc.
SEC File Number	001-40295
Address of Issuer	1100 W. Town & Country Road Suite 1600 Orange CALIFORNIA 92868
Phone	844-310-2247
Name of Person for Whose Account the Securities are To Be Sold	Dawn C. Maroney
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	President

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	E-Trade Finance PO Box 101600 Arlington VA 22210-4600	40643	690527.43	204296493	03/18/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/13/2024	The Common Stock was acquired through the vesting of restricted stock units granted on 03/13/2024 under the Issuer's 2021 Equity Incentive Plan	Alignment Healthcare, Inc. (Issuer)			32500	03/13/2024	n/a
Common Stock	03/13/2025	The Common Stock was acquired through the vesting of restricted stock units granted on 03/13/2025 under the Issuer's 2021 Equity Incentive Plan	Alignment Healthcare, Inc. (Issuer)			39785	03/13/2025	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for Dawn Maroney 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	03/16/2026	30000	524427
Dawn Maroney 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	03/12/2026	29113	507925.32
10b5-1 Sales Plan for Dawn Maroney 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	02/17/2026	30000	618990
10b5-1 Sales Plan for Dawn Maroney 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	01/15/2026	30000	674450.94
10b5-1 Sales Plan for Dawn Maroney 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	01/06/2026	228152	4867600.1
10b5-1 Sales Plan for Dawn Maroney 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	01/02/2026	100000	2003450
Dawn Maroney 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	12/29/2025	282070	5286747.38

144: Remarks and Signature

Remarks	Shares sold pursuant to a sale-to-cover transaction and does not represent a discretionary trade by the reporting person. Actual number of shares sold will be determined based on applicable tax withholding rates and stock price at the time of sale.
Date of Notice	03/16/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Dawn C. Maroney
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)